Contact Dermatitis 61(1):5051 Lee AY (1998) Topical provocation in 31 cases of fixed drug eruption: change of causative drugs in 10 years
Neurosci Lett 415:4548 Rebbeor JF, Connolly GC, Dumont ME, Ballatori N (1998) ATP-dependent transport of reduced glutathione on YCF1, the yeast orthologue of mammalian multidrug resistance-associated proteins
and Psychiatry 62 (6), 596600
Cagrilintide is widely studied as a standalone compound and as part of combination therapy (notably with GLP-1 receptor agonists such as semaglutide) for enhanced metabolic outcomes
They are route-specific doses, not convertible ones: 100 mg drawn into a syringe is 20 to 30 times the intended exposure
If the provider refuses to show you the original packaging, it is a major red flag